FDA rejects EUA for Bharat Biotech’s Covaxin jab

FDA has asked Ocugen, the US partner of Bharat Bio, to launch an additional trial so that it can file for for a full approval

from mint - News https://ift.tt/3pEM1RL
https://ift.tt/eA8V8J